Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
Published on: June 23, 2023
Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 KCNT1 Mutations
Camerin C Passey1, John Erramouspe1, Peter Castellanos2
1Idaho State University College of Pharmacy, Pocatello, Idaho.
Insights
Infantile epilepsy with migrating focal seizures, linked to KCNT1 gene mutations, showed minor response to quinidine. The study highlights quinidine
Area of Science:
- Pediatric Neurology
- Neurogenetics
- Pharmacology
Background:
- Epilepsy of infancy with migrating focal seizures is a severe pediatric neurological disorder.
- This condition is frequently associated with mutations in the KCNT1 gene, leading to neuronal sodium-activated potassium channel dysfunction.
- Developmental delay and treatment-resistant seizures are common outcomes.
Purpose of the Study:
- To investigate the efficacy of quinidine in an infant with two KCNT1 mutations.
- To describe the clinical course and treatment response in this specific case.
- To discuss the drug interaction between quinidine and phenobarbital.
Main Methods:
- Case report of an infant with epilepsy of infancy with migrating focal seizures.
- Genetic analysis identifying two KCNT1 mutations.
- Clinical observation of response to quinidine treatment.
- Pharmacological interaction assessment with phenobarbital.
Main Results:
- The infant with two KCNT1 mutations experienced only minor seizure relief with quinidine.
- Quinidine's potential to reverse KCNT1 gain-of-function was observed, but with limited clinical impact in this case.
- A significant drug interaction between quinidine and phenobarbital was identified.
Conclusions:
- Quinidine may offer limited benefit for seizure control in some infants with multiple KCNT1 mutations.
- The management of epilepsy of infancy with migrating focal seizures requires careful consideration of potential drug interactions, particularly with phenobarbital.
- Further research is needed to optimize therapeutic strategies for KCNT1-related epilepsies.
Abstract:
Epilepsy of infancy with migrating focal seizures is a devastating pediatric neurologic disorder that often results in treatment-resistant seizure activity and developmental delay. The condition has been associated with mutations in the KCNT1 gene that cause a gain of function in neuronal sodium-activated potassium channels. Quinidine has been shown to reverse this gain of function and has recently been used to reduce seizure activity in patients with these mutations. We report the case of an infant with 2 KCNT1 mutations who experienced minor relief with quinidine and discuss the drug's important interaction with phenobarbital.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Mutations in Microorganisms
Point and Frameshift Mutations

